Key facts
- It has raised $770K; the latest was Later Stage VC in Jan 2025.
- Notable investors include Techstars, ARC Innovation Center of Sheba Medical Center, BNP Paribas, Dragones Venture Partners, Sheba Medical Center.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for CaloSense
- ·The full record, as it builds
Funding rounds
No funding rounds for CaloSense are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About CaloSense
Developer of a remote patient monitoring platform designed to relieve pressure on healthcare providers. The company's platform is designed specifically for tracking patient weight and behaviors from smart connected devices with customizable alert triggers, enabling bariatric patients to independently manage their health.
- Sector
- Healthcare
- HQ
- Netanya, Israel
- Founded
- 2020
- Employees
- 11
- Website
- calosense.com/
- Ownership
- Privately Held (backing)
CaloSense doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in CaloSense shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on CaloSense in its N-PORT filings yet. We sweep new filings monthly.